10x Genomics, Inc. (NASDAQ:TXG) Receives $48.50 Average PT from Analysts

10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received an average rating of “Moderate Buy” from the twelve analysts that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating on the company. The […]

Leave a Reply

Your email address will not be published.

Previous post Western Copper and Gold Co. (NYSEAMERICAN:WRN) Forecasted to Post FY2024 Earnings of ($0.02) Per Share
Next post British ISA Plans in Limbo Following Sunak’s Election Call